| Literature DB >> 34919210 |
F R Piersma1, J Neefs1, W R Berger1, N W E van den Berg1, R Wesselink1, S P J Krul1, J R de Groot2.
Abstract
INTRODUCTION: Atrial fibrillation (AF) is the most common arrhythmia and imposes a high burden on the healthcare system. A nurse-led AF outpatient clinic may alleviate the burden on the cardiology outpatient clinic by triaging patients who need care by a cardiologist or general practitioner (GP). However, care and referral patterns after initial assessment in a nurse-led AF outpatient clinic are unknown. We examined the proportion of AF patients assessed in a nurse-led clinic without outpatient follow-up by a cardiologist.Entities:
Keywords: Atrial fibrillation; Nurse practitioner; Outpatient clinic; Referral
Year: 2021 PMID: 34919210 PMCID: PMC9270511 DOI: 10.1007/s12471-021-01651-x
Source DB: PubMed Journal: Neth Heart J ISSN: 1568-5888 Impact factor: 2.854
Fig. 1Workflow of nurse-led atrial fibrillation (AF) outpatient clinic
Fig. 2Flowchart of number of referred patients to nurse-led atrial fibrillation (AF) outpatient clinic and their referral after consultation with dedicated nurse practitioner
Patient characteristics at initial evaluation visit for total AF patient cohort and stratified by remaining under nurse-led care, referral to cardiologist or referral to general practitioner
| Variable | All patients | Nurse-led AF outpatient clinic | Cardiologist | General practitioner | |
|---|---|---|---|---|---|
| Female | 191 (40.0) | 51 (36.7) | 48 (39.7) | 92 (42.2) | 0.55 |
| BMI, kg/m2 | 26 (23–29) | 26 (24–29) | 26 (24–30) | 26 (23–29) | 0.26 |
| Age, years | 67.7 ± 12.5 | 65.3 ± 11.8 | 68.8 ± 12.1 | 68.7 ± 13.0 | 0.02 |
| Age 65–74 years | 292 (61.1) | 73 (52.5) | 74 (61.2) | 145 (66.5) | 0.02 |
| Age ≥ 75 years | 122 (25.5) | 24 (17.3) | 35 (28.9) | 63 (28.9) | 0.03 |
| 0.02 | |||||
| – Paroxysmal | 317 (66.3) | 101 (72.7) | 68 (56.2) | 148 (67.9) | |
| – Persistent | 161 (33.7) | 38 (27.3) | 53 (43.8) | 70 (32.1) | |
| Previous myocardial infarction | 26 (5.4) | 7 (5.0) | 8 (6.6) | 11 (5.0) | 0.80 |
| Previous PCI | 32 (6.7) | 9 (6.5) | 10 (8.3) | 13 (6.0) | 0.72 |
| Hypertension | 245 (51.3) | 61 (43.9) | 72 (59.5) | 112 (51.4) | 0.04 |
| Systolic blood pressure, mm Hg | 138 (125–153) | 137 (125–149) | 140 (127–159) | 136 (124–153) | 0.34 |
| Congestive heart failure | 7 (1.5) | 1 (0.0) | 5 (4.1) | 1 (0.0) | 0.02 |
| Diabetes mellitus | 55 (11.5) | 10 (7.2) | 11 (9.1) | 34 (15.6) | 0.03 |
| Vascular disease | 44 (9.2) | 12 (8.6) | 11 (9.1) | 21 (9.6) | 0.93 |
| < 0.001 | |||||
| – 0 | 60 (12.6) | 24 (17.2) | 11 (9.1) | 25 (11.5) | |
| – 1 | 110 (23.0) | 44 (31.7) | 34 (28.1) | 32 (14.7) | |
| – ≥ 2 | 299 (62.6) | 69 (49.6) | 76 (62.8) | 154 (68.9) | |
| Previous cardiac surgery | 15 (3.1) | 7 (5.0) | 4 (3.3) | 4 (1.8) | 0.24 |
| Postoperative AF | 63 (13.2) | 14 (10.1) | 8 (6.6) | 41 (18.8) | 0.003 |
| 0.18 | |||||
| – AF-related | 22 (4.6) | 9 (6.5) | 6 (5.0) | 7 (3.2) | |
| – Not AF-related | 36 (7.5) | 5 (3.6) | 12 (9.9) | 19 (8.7) | |
| OSAS | 67 (14.0) | 22 (10.8) | 23 (19.0) | 22 (10.1) | 0.13 |
| Valvular disease | 10 (2.1) | 2 (0.0) | 6 (5.0) | 2 (0.0) | 0.04 |
| 0.76 | |||||
| – Hyperthyroidism | 16 (3.3) | 2 (1.4) | 4 (3.3) | 8 (3.7) | |
| – Hypothyroidism | 14 (2.9) | 5 (3.6) | 3 (2.5) | 8 (3.7) | |
| Family history | 111 (23.2) | 37 (26.6) | 29 (23.9) | 45 (20.6) | 0.32 |
| 0.01 | |||||
| – I—no | 139 (29.1) | 30 (21.6) | 28 (23.1) | 81 (37.2) | |
| – II—mild | 103 (21.5) | 34 (24.5) | 33 (27.3) | 36 (16.5) | |
| – III—severe | 188 (39.3) | 61 (43.9) | 50 (41.3) | 77 (35.3) | |
| – IV—disabling | 32 (6.7) | 9 (6.5) | 9 (7.4) | 14 (6.4) | |
| Creatinine | 81 (67–95) | 80 (67–91) | 84 (71–96) | 80 (66–103) | 0.32 |
| ProBNP | 935 (133–1312) | 449 (119–878) | 848 (198–1312) | 414 (113–1372) | 0.52 |
| CRP | 4.3 (1.4–13) | 2.7 (0.9–9.1) | 2.1 (1.1–6.8) | 5.9 (2.2–27.4) | 0.02 |
Data are n (%), median (interquartile range) or mean ± standard deviation
AF atrial fibrillation, BMI body mass index, CRP C-reactive protein, CVA cerebrovascular accident, eGFR estimated glomerular filtration rate, EHRA class European Heart Rhythm Association symptom classification, ProBNP pro-brain natriuretic peptide, OSAS obstructive sleep apnoea syndrome, PCI percutaneous coronary intervention
a P-value for difference between referral groups
Distribution of antiarrhythmic drug prescription to AF patients at initial evaluation visit stratified by remaining under nurse-led care, referral to cardiologist or referral to general practitioner
| Antiarrhythmic drug class | Nurse-led AF outpatient clinic | Cardiologist | General practitioner | |
|---|---|---|---|---|
| Class 1c | 6 (4.3) | 7 (5.8) | 5 (2.3) | 0.25 |
| Class II | 75 (54.0) | 62 (51.2) | 118 (54.1) | 0.87 |
| Class III | 11 (7.9) | 9 (7.4) | 5 (2.3) | 0.03 |
| Class IV | 3 (2.2) | 7 (5.8) | 5 (2.3) | 0.15 |
| Digoxin | 17 (12.2) | 14 (11.5) | 31 (14.2) | 0.77 |
Data are n (%)
AF atrial fibrillation
Anticoagulation therapy after triage stratified for remaining under nurse-led care, referral to cardiologist or referral to general practititioner
| Variable | Nurse-led AF outpatient clinic | Cardiologist | General practitioner | |
|---|---|---|---|---|
| < 0.001* | ||||
| – Vitamin K antagonist | 10 (7.2) | 21 (17.4) | 48 (22.0) | |
| – Non-vitamin K antagonist | 91 (65.5) | 67 (55.4) | 91 (41.7) |
Data are n (%)
AF atrial fibrillation
* P-value refers to ratio between patients receiving vitamin K antagonists those receiving non-vitamin K antagonists per category